Julie Rubinstein
President and COO · 19 filings · Latest: Oct 14, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | Julie Rubinstein | President and COO | Mar 4, 2026 | Sale | $16.60 | 30,941 | $513.6K | 579,573 | |
ADPT | Julie Rubinstein | President and COO | Mar 4, 2026 | Option Exercise | $9.05 | 26,603 | $240.7K | 610,514 | |
ADPT | Julie Rubinstein | President and COO | Mar 3, 2026 | Sale | $15.67 | 30,941 | $484.8K | 583,911 | |
ADPT | Julie Rubinstein | President and COO | Mar 3, 2026 | Option Exercise | $9.05 | 26,603 | $240.7K | 614,852 | |
ADPT | JULIE RUBINSTEIN | — | Mar 3, 2026 | Proposed Sale | $16.12 | 1,206,661 | $19.5M | — |
← Previous
Page 6 of 6